Tower Research Capital (TRC)’s CytoMed Therapeutics GDTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-13
Closed -$28 5798
2024
Q1
$28 Sell
13
-869
-99% -$1.87K ﹤0.01% 5741
2023
Q4
$4.32K Buy
+882
New +$4.32K ﹤0.01% 4968